口唇ヘルペス治療の世界市場

口唇ヘルペス治療の世界市場は2030年までに13億米ドルに達する見込み

2024年に9億9,300万米ドルと推定される口唇ヘルペス治療の世界市場は、2024～2030年の分析期間にCAGR 4.8%で成長し、2030年には13億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである局所治療薬は、CAGR 3.8%を記録し、分析期間終了時には7億3,510万米ドルに達すると予測されます。経口治療セグメントの成長率は、分析期間中CAGR 6.4%と推定されます。

米国市場は2億7,050万米ドルと推定、中国はCAGR7.4％で成長予測

米国の口唇ヘルペス治療市場は、2024年に2億7,050万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.4%として、2030年までに2億5,660万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.4%と4.7%と予測されています。欧州では、ドイツがCAGR 3.0%で成長すると予測されています。

世界の口唇ヘルペス治療市場- 主要動向と促進要因のまとめ

口唇ヘルペス治療が皮膚科と抗ウイルス療法で持続的に注目される理由とは？

主に単純ヘルペスウイルス1型（HSV-1）によって引き起こされる口唇ヘルペスは、依然として世界的に最も一般的で再発を繰り返すウイルス感染症の一つです。人口のかなりの部分が罹患しているこれらの病変は、不快感や審美的な懸念を引き起こすだけでなく、感染の危険性もあります。ストレス、病気、日光曝露などが引き金となって発生する再発性疾患であるため、症状を管理し、発症期間を短縮し、再発を抑制する効果的な治療法が長期にわたって求められています。

口唇ヘルペスは、生命を脅かす疾患ではないにもかかわらず、特に目に見えたり痛みを伴う場合には、患者のQOLや社会的交流に大きな影響を及ぼします。市販薬（OTC）や処方薬による治療が可能であることに加え、早期介入に対する意識の高まりにより、治療を希望する患者層が拡大しています。消費者の健康動向がセルフケアを重視する中、混乱を最小限に抑え治癒を早める、即効性があり使い勝手の良い抗ウイルス剤へのシフトは明らかです。

有効性と利便性を向上させるために、治療クラスと投与形態はどのように進化しているか？

アシクロビル、バラシクロビル、ファムシクロビルなどの抗ウイルス剤は、外用剤と経口剤の両方で利用可能であり、第一選択薬としての役割を果たし続けています。重度または頻度の高い感染症には全身治療薬が望ましいが、局所用クリームやジェルは局所的な症状を迅速に緩和し、使いやすいです。最近の革新的な治療法としては、リポソームデリバリーシステム、ハイドロコロイドパッチ、生体接着フィルムなどがあり、薬物の保持とバリア保護を向上させ、病変部位での治療効果を高めています。

口唇ヘルペスに特化したマイクロカレント装置や光治療器などの新たな送達形態も、薬理作用のある薬剤を使用せずにウイルスの複製を抑え、病変の消失を早める可能性があることから、消費者の関心を集めています。これらの補助技術は、消費者に直接販売されることも多く、薬物を使用しない治療や併用治療を求める消費者にアピールしています。遠隔皮膚科やe-pharmacyプラットフォームの成長は、処方抗ウイルス薬への迅速なアクセスをさらに後押しし、個別化された発生管理戦略の採用に拍車をかけています。

市場普及を牽引する消費者セグメントとヘルスケアチャネルは？

若年層と中年層、特に社会的関与が高く、外見にこだわるライフスタイルを持つ層は、最も積極的な消費者です。この層は、審美的・社会的混乱を最小限に抑えるために早期の症状コントロールを求め、しばしば即効性のあるOTC製品を好みます。また、初めてこの病気にかかった人の認知度が高まり、主流メディアで口唇ヘルペスの話題が取り上げられるようになったことで、偏見が薄れ、より幅広い年齢層で治療需要が拡大しています。

OTC治療薬は幅広く入手可能であり、薬剤師が推奨していることから、小売店やオンライン薬局が主要な販売チャネルとなっています。皮膚科クリニックやプライマリ・ケア診療所では、特に全身性抗ウイルス薬や鑑別診断が必要な、慢性または複雑な症例の管理が引き続き行われています。eコマースの成長と消費者へのダイレクトマーケティングにより、医薬品ブランドは、利便性を重視したサブスクリプションモデル、バンドル製品、アドヒアランスとブランドロイヤリティの向上を目的とした教育コンテンツで、特定の消費者層をターゲットにすることが可能になっています。

規制、ブランド、価格戦略はどのように競合のポジショニングを形成しているか？

口唇ヘルペス治療市場は競争が激しく、数多くのジェネリック製剤とブランド製剤が、効能効果、即効性、ユーザーエクスペリエンスで競合しています。規制経路は地域によって異なり、処方箋が必要な抗ウイルス治療薬もあれば、OTC薬もあります。このような規制の細分化は、価格設定、マーケティングの柔軟性、市場アクセスに影響を与えます。各ブランドは、斬新なデリバリー・フォーマット、保湿剤や麻酔剤などの付加価値成分、信頼性を高めるための臨床医の推薦などによって差別化を図っています。

特にOTC分野では価格感度が顕著で、消費者の選択は知覚された効果、スピード、緩和の持続時間に影響されます。企業は、店頭配置、インフルエンサーマーケティング、デジタルヘルスプラットフォームを組み合わせたマルチチャネル・ブランディング戦略を活用し、消費者の信頼を築き、発症時の衝動買いを誘発しています。口唇ヘルペス治療がセルフケアの領域へとさらにシフトするにつれ、パッケージデザイン、塗りやすさ、ユーザー教育が、ブランド嗜好や治療継続においてますます重要な役割を果たすようになっています。

口唇ヘルペス治療市場の成長を促進する要因は何か？

市場の成長は、HSV-1の世界の有病率の高さ、消費者の意識の高まり、病変の持続期間と可視性を短縮する即効性のある利用しやすい治療薬への強い嗜好によってもたらされています。自己管理医療へのシフトは、健康製品をオンラインで購入することの快適性の高まりと相まって、既存地域と新興地域の両方で需要を拡大しています。ドラッグの製剤、デリバリー・システム、補助器具の革新により、特に頻繁に発症する風邪を管理する消費者にとっては、よりオーダーメイドの治療が可能になりつつあります。

口唇ヘルペスに対するスティグマ（烙印）が低下し、製品革新が加速する中、有効性、慎重さ、利便性のバランスを取ることができるブランドは、持続的な市場シェアを獲得する上で最も有利な立場になると思われます。治療プロバイダーがデジタルヘルスツールをさらに統合し、標的治療へのアクセスを改善し、進化する消費者の期待に沿うことができるかどうかが、市場の次の段階を形成することになります。

セグメント

製品タイプ（外用治療薬、経口治療薬、光治療薬）;口唇ヘルペスタイプ（一次感染、再発性感染）;年齢層（小児、思春期、成人）;販売チャネル（病院薬局、小売薬局、オンライン薬局）

調査対象企業の例（全43件）

• Abbott Laboratories
• AbbVie Inc.
• Amgen Inc.
• Aurobindo Pharma Ltd.
• Bausch Health Companies Inc.
• Bayer AG
• Biofrontera AG
• Bristol-Myers Squibb Company
• Church & Dwight Co., Inc.
• Dr. Reddy's Laboratories Ltd.
• Ferring Pharmaceuticals
• GSK plc
• Haleon plc
• HRA Pharma
• Johnson & Johnson
• Meda Pharmaceuticals
• Mylan N.V.（now part of Viatris Inc.）
• Novartis AG
• Perrigo Company plc
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

無料アップデート弊社のお客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Cold Sore Treatment Market to Reach US$1.3 Billion by 2030

The global market for Cold Sore Treatment estimated at US$993.0 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Topical Treatments, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$735.1 Million by the end of the analysis period. Growth in the Oral Treatments segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$270.5 Million While China is Forecast to Grow at 7.4% CAGR

The Cold Sore Treatment market in the U.S. is estimated at US$270.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$256.6 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Cold Sore Treatment Market - Key Trends & Drivers Summarized

Why Is Cold Sore Treatment a Persistent Focus in Dermatology and Antiviral Therapy?

Cold sores, caused primarily by herpes simplex virus type 1 (HSV-1), remain among the most common and recurring viral infections globally. Affecting a significant portion of the population, these lesions not only cause discomfort and aesthetic concern but also pose transmission risks. The recurrent nature of outbreaks-triggered by stress, illness, or sun exposure-has sustained long-term demand for effective treatment options that can manage symptoms, shorten episode duration, and reduce recurrence.

Despite being a non-life-threatening condition, cold sores significantly impact patient quality of life and social interactions, especially in visible or painful cases. The availability of over-the-counter (OTC) and prescription therapies, along with growing awareness of early intervention, has expanded the treatment-seeking population. As consumer health trends emphasize self-care, there is a clear shift toward fast-acting, user-friendly antiviral solutions that minimize disruption and speed healing.

How Are Therapeutic Classes and Delivery Formats Evolving to Improve Efficacy and Convenience?

Antiviral agents such as acyclovir, valacyclovir, and famciclovir continue to serve as first-line therapies, available in both topical and oral formulations. While systemic drugs are preferred for severe or frequent outbreaks, topical creams and gels offer rapid localized relief and ease of use. Recent innovations include liposomal delivery systems, hydrocolloid patches, and bioadhesive films that improve drug retention and barrier protection-enhancing treatment effectiveness at the lesion site.

Emerging delivery formats such as cold sore-specific microcurrent devices and light therapy tools are also gaining consumer interest for their potential to reduce viral replication and speed lesion resolution without pharmacological agents. These adjunctive technologies, often marketed directly to consumers, appeal to individuals seeking drug-free or combination treatments. The growth of teledermatology and e-pharmacy platforms is further supporting fast access to prescription antivirals and fueling adoption of personalized outbreak management strategies.

Which Consumer Segments and Healthcare Channels Are Driving Market Penetration?

Young adults and middle-aged populations-particularly those with high social engagement and appearance-conscious lifestyles-represent the most proactive cold sore treatment consumers. This demographic seeks early symptom control to minimize aesthetic and social disruption, often favoring rapid-onset OTC products. Increasing awareness among first-time sufferers and growing acceptance of cold sore discussions in mainstream media are also reducing stigma and expanding treatment demand among broader age groups.

Pharmacies, both retail and online, serve as the primary distribution channels, given the wide availability of OTC treatments and pharmacist-led recommendations. Dermatology clinics and primary care practices continue to manage chronic or complicated cases, especially where systemic antivirals or differential diagnosis are warranted. E-commerce growth and direct-to-consumer marketing are enabling pharmaceutical brands to target specific consumer segments with convenience-based subscription models, bundled offerings, and educational content designed to improve adherence and brand loyalty.

How Are Regulatory, Branding, and Pricing Strategies Shaping Competitive Positioning?

The cold sore treatment market is highly competitive, with numerous generic formulations and brand-name options competing on efficacy claims, speed of action, and user experience. Regulatory pathways vary across regions, with some antiviral treatments requiring prescriptions and others available OTC. This regulatory fragmentation influences pricing, marketing flexibility, and access across markets. Brands are differentiating through novel delivery formats, value-added ingredients like moisturizers or anesthetics, and clinician endorsements to reinforce credibility.

Pricing sensitivity is notable, especially in OTC segments, where consumer choices are influenced by perceived effectiveness, speed, and duration of relief. Companies are leveraging multi-channel branding strategies-combining in-store placement, influencer marketing, and digital health platforms-to build consumer trust and trigger impulse purchases during outbreak onset. As cold sore treatments shift further into self-care territory, packaging design, ease of application, and user education are playing increasingly important roles in brand preference and treatment adherence.

What Are the Factors Driving Growth in the Cold Sore Treatment Market?

Market growth is being driven by high global prevalence of HSV-1, increased consumer awareness, and a strong preference for fast-acting, accessible therapies that reduce lesion duration and visibility. The shift toward self-managed care, combined with rising comfort in purchasing health products online, is expanding demand across both established and emerging regions. Innovation in drug formulations, delivery systems, and adjunctive devices is enabling more tailored treatment experiences, especially for consumers managing frequent outbreaks.

As the stigma around cold sores continues to decline and product innovation accelerates, brands that can balance efficacy, discretion, and convenience will be best positioned for sustained market share. Whether treatment providers can further integrate digital health tools, improve access to targeted therapies, and align with evolving consumer expectations will shape the market’s next phase-where cold sore management becomes not just about symptom relief, but about proactive, confident personal care.

SCOPE OF STUDY:

The report analyzes the Cold Sore Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Topical Treatments, Oral Treatments, Light-based Treatments); Cold Sore Type (Primary Outbreaks, Recurrent Outbreaks); Age Group (Children, Adolescents, Adults); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abbott Laboratories
• AbbVie Inc.
• Amgen Inc.
• Aurobindo Pharma Ltd.
• Bausch Health Companies Inc.
• Bayer AG
• Biofrontera AG
• Bristol-Myers Squibb Company
• Church & Dwight Co., Inc.
• Dr. Reddy's Laboratories Ltd.
• Ferring Pharmaceuticals
• GSK plc
• Haleon plc
• HRA Pharma
• Johnson & Johnson
• Meda Pharmaceuticals
• Mylan N.V. (now part of Viatris Inc.)
• Novartis AG
• Perrigo Company plc
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Cold Sore Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • High Recurrence Rates of HSV-1 Infections Sustain Demand for Over-the-Counter and Prescription Cold Sore Treatments
  • Topical Antivirals and Moisturizing Agents Remain Mainstay Options in Early Symptom Management
  • Innovation in Patch-Based and Invisible Gel Formulations Enhances Discretion and Wearability
  • Online Dermatology Platforms and E-Pharmacies Expand Access to Cold Sore Therapy Products
  • Consumer Preference for Natural and Zinc-Based Remedies Supports Growth in Alternative Treatments
  • Mobile Apps With Flare-Up Trackers and Reminders Improve Adherence to Suppression Therapy
  • Prescription Therapies See Uptick in Use for Immunocompromised and High-Risk Populations
  • Cold Sore Treatment Bundles Including Lip Balms, Pain Relief, and Antiseptic Swabs Gain Popularity
  • Increased Awareness of Triggers Like Stress and Sun Exposure Drives Demand for Preventive Options
  • Packaging Innovation and Pocket-Sized Formats Cater to On-the-Go Use Cases
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cold Sore Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cold Sore Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cold Sore Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Cold Sore Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Topical Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Topical Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Topical Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Oral Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Oral Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Oral Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Light-based Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Light-based Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Light-based Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Retail Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Online Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Primary Outbreaks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Primary Outbreaks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Primary Outbreaks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Recurrent Outbreaks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Recurrent Outbreaks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Recurrent Outbreaks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Children by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Children by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Children by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Adolescents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Adolescents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Adolescents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Adults by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• JAPAN
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• CHINA
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• EUROPE
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Cold Sore Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Cold Sore Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• FRANCE
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 101: France Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• GERMANY
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 137: UK Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Cold Sore Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• INDIA
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 212: India Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Cold Sore Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Cold Sore Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Cold Sore Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Cold Sore Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
• AFRICA
  • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030

IV. COMPETITION